🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This will be a randomized, double-blind, placebo- controlled cross-over stu...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-01
Trial ID
NCT01516372
Treatments Being Tested
Novo Nordisk is developing a new study medicine, Etavopivat, to treat indiv...
Status
Completed
Location
PAREXEL Intl - EPCU-Baltimore
Start Date
2025-06-09
Trial ID
NCT07023029
Treatments Being Tested
The purpose of this study is to assess the effects of multiple doses of an ...
Status
Completed
Location
Multiple Locations
Start Date
2014-12-04
Trial ID
NCT02307864
Treatments Being Tested
This study will assess the effects of Bemnifosbuvir on cardiac repolarizati...
Status
Completed
Location
Atea Study Site
Start Date
2023-04-25
Trial ID
NCT05905484
Treatments Being Tested
This study is comprised of two parts. The purpose of the first part of this...
Status
Completed
Location
Altasciences Clinical Kansas, Inc
Start Date
2022-06-22
Trial ID
NCT05478278
Treatments Being Tested
This study is to evaluate the effects of single therapeutic and supratherap...
Status
Completed
Location
Celerion
Start Date
2016-04-01
Trial ID
NCT04867980
Treatments Being Tested
This is a Phase I, single-center, double-blinded, randomized, placebo-contr...
Status
Completed
Location
Quintiles Phase I Services - Overland Park
Start Date
2012-09
Trial ID
NCT01674218
Treatments Being Tested
This study is designed to evaluate the effect of multiple doses of lumacaft...
Status
Completed
Location
Multiple Locations
Start Date
2013-06
Trial ID
NCT01910415
Treatments Being Tested
This will be a double-blind, 4-period, randomized, cross-over study conduct...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-01-10
Trial ID
NCT01756495
Treatments Being Tested
The purpose of this study is to evaluate the potential effect of naltrexone...
Status
Completed
Location
Multiple Locations
Start Date
2016-04
Trial ID
NCT02735603
Treatments Being Tested